Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

45.67 -0.48 (-1.03%)
Streaming Delayed Price Updated: 10:50 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,730,402
Open 46.10
Bid (Size) 45.67 (10)
Ask (Size) 45.68 (7)
Prev. Close 46.15
Today's Range 45.63 - 46.32
52wk Range 42.96 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.43%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials
Johnson & Johnson and Protagonist Therapeutics announced new data from their Phase 3 studies to treat severe plaque psoriasis. 
Via Benzinga

Performance

YTD
-19.6%
-19.6%
1 Month
-5.2%
-5.2%
3 Month
-2.5%
-2.5%
6 Month
-24.0%
-24.0%
1 Year
-7.7%
-7.7%

More News

Read More
J&J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Study
Via Stocktwits
Advancing Cancer Research Brings New Hope for Patients Worldwide
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Advancing Cancer Research Brings New Hope for Patients Worldwide
Via FinancialNewsMedia
Topics Artificial Intelligence Intellectual Property
Bristol Myers Squibb Announces Dividend
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
From Bristol Myers Squibb
Via Business Wire
3 Great High-Yield Dividend Stocks to Buy in September
Via The Motley Fool
BRISTOL-MYERS SQUIBB CO (NYSE:BMY): A High-Yield Dividend Stock with Strong Profitability
Via Chartmill
The Specter of Stagflation: A Looming Threat to Global Markets
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz
Via Benzinga
Topics ETFs Government
The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now
Via The Motley Fool
Topics Intellectual Property
BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy
Via Benzinga
S&P 500 Soars to Uncharted Territory: Is the Market Overvalued or Justified by a New Era of Growth?
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 4% Dividend Yields
Via Benzinga
Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug
Via Benzinga
2 Top Dividend Stocks to Buy With Less Than $50
Via The Motley Fool
Topics Intellectual Property
2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off
Via StockStory
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles
Via Benzinga
Topics Stocks
Cytokinetics And The 'Provocative Conversation' That Could Rewrite Heart Disease
Via Investor's Business Daily
Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Branded Pharmaceuticals Stocks Q2 Recap: Benchmarking Bristol-Myers Squibb (NYSE:BMY)
Via StockStory
Topics Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 45.67
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 09/18/25 10:50 AM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 101.50B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 101B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.